Frequent grade ≥ 3treatment-related AEs were thrombocytopenia (48.8%), anemia (24.4%), neutropenia (19.5%), and leukopenia (12.2%). Frequent nonhematologic treatment-relatedall-grade AEs were skin pigmentation (53.7%) and elevated creatine kinase (48.8%), alanine aminotransferase (31.7%), and aspartate aminotransferase (26.8%). The gene discussed is GPT; the disease is Decreased total neutrophil count.